...
首页> 外文期刊>RSC Advances >NIR-laser-triggered smart full-polymer nanogels for synergic photothermal-/chemo-therapy of tumors
【24h】

NIR-laser-triggered smart full-polymer nanogels for synergic photothermal-/chemo-therapy of tumors

机译:NIR激光触发的智能全聚合物纳米凝电池,用于协同光热 - /化疗肿瘤治疗

获取原文

摘要

Near infrared (NIR, λ = 700–1100 nm) laser-triggered drug delivery systems (DDs) have attracted great interest for the synergic photothermal-/chemo-therapy of tumors, and a prerequisite for their development is to obtain biocompatible and efficient nanoplatforms that possess excellent photothermal and controllable (on/off) drug-release abilities. Herein, we have designed and fabricated full-polymer smart nanogels (PNA–CS–PPy–DOX) as novel NIR-DDs, by using polypyrrole (PPy) as the photothermal agent, PNA–chitosan (PNA–CS) with a lower critical solution temperature (LCST) of 42 °C as the carrier and the doxorubicin (DOX) as the model of the anticancer drugs. The aqueous dispersion of PNA–CS–PPy–DOX shows increased photoabsorption with a wavelength from 600 to 1100 nm. The temperature of its aqueous dispersions (PPy concentration: 1–20 μg mL ~(?1) ) goes up quickly from room-temperature to 32.4–60.3 °C in 5 min under the irradiation of a 915 nm laser (intensity: 2.0 W cm ~(?2) ), verifying the excellent photothermal performance. To simulate the in vivo drug delivery, a typical aqueous PNA–CS–PPy–DOX (~10 mg mL ~(?1) ) dispersion is covered by chicken skin as the model of biological tissue. After the irradiation of the 915 nm laser (intensity: 2.0 W cm ~(?2) ), the temperature of the dispersion goes up to higher than 42 °C (LCST of PNA–CS), resulting in the release of the drug. As a result, the cumulative release of DOX from PNA–CS–PPy–DOX increases from 1.67% (at 0 min) to 48.53% (at 14 min of irradiation), indicating the excellent intelligence and controllability. Subsequently, the PNA–CS–PPy–DOX dispersion is injected into the tumor of the mice. Under the irradiation of the 915 nm laser, the cancer cells can be efficiently destroyed, and the tumor suffers significant ablation, indicating the excellent synergic photothermal-/chemo-therapy effects compared with the single photothermal therapy or chemotherapy effect. Therefore, the present PNA–CS–PPy–DOX nanogels have great superiority as a biocompatible and efficient nanoagent for the synergic photothermal-/chemo-therapy of tumors.
机译:近红外线(NIR,λ= 700-1100nm)激光触发的药物递送系统(DDS)吸引了对肿瘤的协同影式/化学治疗感兴趣,并且其发展的先决条件是获得生物相容性和有效的纳米纳薄形式具有优异的光热和可控(开/关)药物释放能力。在此,我们通过使用聚吡咯(PPY)作为光热试剂,PNA-壳聚糖(PNA-CS)具有较低的临界溶液温度(LCST)为42°C作为载体和多柔比星(DOX)作为抗癌药物的模型。 PNA-CS-PPY-DOX的水分散体显示出增加的光吸收,波长为600至1100nm。其水分水分散体的温度(PPY浓度:1-20μgml〜(β1))在5分钟内从室温快到32.4-60.3°C,在915nm激光的照射下(强度:2.0W) CM〜(?2)),验证优异的光热性能。为了模拟体内药物递送,鸡皮覆盖典型的PNA-CS-PPY-DOX(〜10mg mL〜(β1)分散体作为生物组织的模型。在915nm激光照射后(强度:2.0W cm〜(Δ2)),分散体的温度高于42℃(PNA-Cs的LCST),导致药物的释放。结果,来自PNA-CS-PPY-DOX的DOX的累积释放从1.67%(0分钟)增加到48.53%(在辐照14分钟),表明出色的智力和可控性。随后,将PNA-CS-PPY-DOX分散体注入小鼠的肿瘤中。在915nm激光的照射下,可以有效地破坏癌细胞,并且肿瘤患有显着的烧蚀,表明与单一光热疗或化疗效果相比,表明优异的协同光热/化学治疗效果。因此,本发明的PNA-CS-PPY-DOX纳米凝胶具有良好的优越性,作为用于肿瘤的协同光热/化学疗法的生物相容和有效的纳米型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号